Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02663193 · ClinicalTrials.gov registry record

Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability

A clinical trial of Prostate Cancer, sponsored by Janssen Scientific Affairs.

Completed
Registry status
108
Enrollment target
20
Study locations

NCT02663193 is a study of Prostate Cancer that has completed, run by Janssen Scientific Affairs. The registered enrollment target is 108 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (82% lower). The trial reports 20 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02663193, a study of Prostate Cancer, has completed, sponsored by Janssen Scientific Affairs.

COMPLETED
Registry status
108 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to characterize the tolerability profiles of enzalutamide and abiraterone acetate (with prednisone) -with specific focus on central nervous system (CNS) tolerability-and quality of life (QoL) after approximately 2 months of participants starting treatment with one of these agents for metastatic castration-resistant prostate cancer (mCRPC).

Conditions Studied

Prostate Cancer

Interventions

  • OTHER No Intervention

Study Locations (20)

New Jersey

  • - Englewood
  • - Lawrenceville
  • - Morristown

Indiana

  • - Indianapolis
  • - Jeffersonville

New York

  • - Poughkeepsie
  • - Syracuse

Pennsylvania

  • - Bala-Cynwyd
  • - Lancaster

South Carolina

  • - Charleston
  • - Myrtle Beach

Alabama

  • - Homewood

California

  • - La Mesa

Colorado

  • - Wheat Ridge

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2015-12
Est. Completion 2017-01

Sponsor

Janssen Scientific Affairs

37 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02663193

The ClinicalTrials.gov registry entry for NCT02663193 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (82% lower). The listed sponsor is Janssen Scientific Affairs, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.

NCT02663193 reports 20 study locations spanning 14 distinct geographic areas - top geographies include New Jersey, Indiana, New York.

Frequently Asked Questions

What is clinical trial NCT02663193 about?

NCT02663193 is a clinical study titled "Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability". The purpose of this study is to characterize the tolerability profiles of enzalutamide and abiraterone acetate (with prednisone) -with specific focus on central nervous system (CNS) tolerability-and quality of life (QoL) after approximately 2 months of participants starting treatment with one of the...

What is the current status of trial NCT02663193?

This trial is currently completed. The enrollment target is 108 participants. The study started on 2015-12. Estimated completion is 2017-01.

What conditions does trial NCT02663193 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT02663193?

The interventions under investigation include: No Intervention (OTHER).

Who is sponsoring clinical trial NCT02663193?

This trial is sponsored by Janssen Scientific Affairs, which has 37 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02663193 being conducted?

This trial has 20 study locations across Alabama, California, Colorado, Florida, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.